ArticleComputational intelligence and neuroscience2022
Cancer Detection and Prediction Using Genetic Algorithms.
Article in Computational intelligence and neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Machine Learning Analysis of RNA-seq Data for Diagnostic and Prognostic Prediction of Colon Cancer.Sensors (Basel, Switzerland) · 2023Article
- Retracted: Cancer Detection and Prediction Using Genetic Algorithms.Computational intelligence and neuroscience · 2023Article
- A Novel Hybrid Convolutional Neural Network Approach for the Stomach Intestinal Early Detection Cancer Subtype Classification.Computational intelligence and neuroscience · 2022Article
- Biomedical Diagnosis of Leukemia Using a Deep Learner Classifier.Computational intelligence and neuroscience · 2022Article
Corrections and comments
- Retraction · 2023-11-29Compromised Peer Review · Investigation by Journal/Publisher · Investigation by Third Party · Paper Mill · Unreliable Results and/or Conclusions ·
- Retracted
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer is a wide category of diseases that is caused by the abnormal, uncontrollable growth of cells, and it is the second leading cause of death globally. Screening, early diagnosis, and prediction of recurrence give patients the best possible chance for successful treatment. However, these tests can be expensive and invasive and the results have to be interpreted by experts. Genetic algorithms (GAs) are metaheuristics that belong to the class of evolutionary algorithms. GAs can find the optimal or near-optimal solutions in huge, difficult search spaces and are widely used for search and optimization. This makes them ideal for detecting cancer by creating models to interpret the results of tests, especially noninvasive. In this article, we have comprehensively reviewed the existing literature, analyzed them critically, provided a comparative analysis of the state-of-the-art techniques, and identified the future challenges in the development of such techniques by medical professionals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.